Prostate and Urologic Cancer Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer Genistein, Laboratory Biomarker Analysis, Pharmacological Study, Placebo Administration, Therapeutic Conventional Surgery NCT00118040 National Cancer Institute (NCI) Active, not recruiting
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Rilimogene Galvacirepvec, Placebo Administration NCT02326805 National Cancer Institute (NCI) Active, not recruiting